Apimeds Pharmaceuticals US, Inc. is a development-stage biopharmaceutical company whose Q2 2026 print (period ended June 30, 2026, filed August 14, 2026) reads more like a micro-cap crypto treasury than a clinical-stage drug developer. The company that once traded on the strength of Apitox, a honeybee-venom-based therapy for knee osteoarthritis, now carries $116.7 million of digital assets on a $127.6 million balance sheet, with the entire $35.3 million H1 2026 net loss driven by a $35.3 million unrealized mark-to-market loss on its Bitcoin and NILA token holdings, against just $0.3 million of cash and a $5.0 million note that matured on July 1, 2026 and remains in active default discussions.
The load-bearing observation: APUS completed a 1-for-10 reverse stock split on July 24, 2026 to lift its share price above NYSE American's continued-listing minimum, immediately re-listed the stock under a new CUSIP, and now trades at $4.28 against a 52-week range of $3.39 to $59.70 (the high water mark was set before the split-adjusted history of the prior MindWave-affiliated entity). The reverse split, the going-concern qualification, the matured note, and the senior secured convertible note whose forbearance expired on June 30, 2026 with no extension all arrived within the same thirty-day window. The equity, in our view, is now an option on whether management can monetize the digital-asset treasury before the bio-pharma program burns through the remaining cash.
The single most important number for the next twelve months is not the bio-pharma R&D line ($0.96 million in Q2 2026), not the $5.0 million matured note, and not the $10.9 million senior secured convertible note. It is the value of the $116.7 million digital-asset stack and management's willingness to liquidate it, because every other obligation on the balance sheet is denominated in cash the company does not have. The falsifiable clock is the Q3 2026 10-Q (expected mid-November 2026), which discloses whether the matured note has been repaid, extended, or converted, and whether the $116.7 million of digital assets has been sold, pledged, or marked down further.